39 Targeting the lactate transporter monocarboxylate transporter 1 constitutes a new therapeutic modality that disrupts a fundamental metabolic symbiosis in tumours
Publication
, Conference
Sonveaux, P; Dewhirst, MW; Feron, O
Published in: European Journal of Cancer Supplements
June 2010
Duke Scholars
Published In
European Journal of Cancer Supplements
DOI
ISSN
1359-6349
Publication Date
June 2010
Volume
8
Issue
5
Start / End Page
10 / 10
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Sonveaux, P., Dewhirst, M. W., & Feron, O. (2010). 39 Targeting the lactate transporter monocarboxylate transporter 1 constitutes a new therapeutic modality that disrupts a fundamental metabolic symbiosis in tumours. In European Journal of Cancer Supplements (Vol. 8, pp. 10–10). Elsevier BV. https://doi.org/10.1016/s1359-6349(10)70848-x
Sonveaux, P., M. W. Dewhirst, and O. Feron. “39 Targeting the lactate transporter monocarboxylate transporter 1 constitutes a new therapeutic modality that disrupts a fundamental metabolic symbiosis in tumours.” In European Journal of Cancer Supplements, 8:10–10. Elsevier BV, 2010. https://doi.org/10.1016/s1359-6349(10)70848-x.
Sonveaux P, Dewhirst MW, Feron O. 39 Targeting the lactate transporter monocarboxylate transporter 1 constitutes a new therapeutic modality that disrupts a fundamental metabolic symbiosis in tumours. In: European Journal of Cancer Supplements. Elsevier BV; 2010. p. 10–10.
Sonveaux, P., et al. “39 Targeting the lactate transporter monocarboxylate transporter 1 constitutes a new therapeutic modality that disrupts a fundamental metabolic symbiosis in tumours.” European Journal of Cancer Supplements, vol. 8, no. 5, Elsevier BV, 2010, pp. 10–10. Crossref, doi:10.1016/s1359-6349(10)70848-x.
Sonveaux P, Dewhirst MW, Feron O. 39 Targeting the lactate transporter monocarboxylate transporter 1 constitutes a new therapeutic modality that disrupts a fundamental metabolic symbiosis in tumours. European Journal of Cancer Supplements. Elsevier BV; 2010. p. 10–10.
Published In
European Journal of Cancer Supplements
DOI
ISSN
1359-6349
Publication Date
June 2010
Volume
8
Issue
5
Start / End Page
10 / 10
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis